Glycogen synthase kinase-3β suppresses the expression of protein phosphatase methylesterase-1 through β-catenin
Nana Jin1, Ruirui Shi1, Yanli Jiang1
1Key Laboratory of Neuroregeneration of Jiangsu and Ministry of Education of China, Co-Innovation Center of Neuroregeneration, Nantong University, Nantong, Jiangsu 226001, China.
Abstract:
Protein phosphatase 2A (PP2A) is the major tau phosphatase. Its activity toward tau is regulated by the methylation of PP2A catalytic subunit (PP2Ac) at Leu309. Protein phosphatase methylesterase-1 (PME-1) demethylates PP2Ac and suppresses its activity. We previously found that glycogen synthase kinase-3β (GSK-3β) suppresses PME-1 expression. However, the underlying molecular mechanism is unknown. In the present study, we analyzed the promoter of PME-1 gene and found that human PME-1 promoter contains two lymphoid enhancer binding factor-1/T-cell factor (LEF1/TCF) cis-elements in which β-catenin serves as a co-activator. β-catenin acted on these two cis-elements and promoted PME-1 expression. GSK-3β phosphorylated β-catenin and suppressed its function in promoting PME-1 expression. Inhibition and activation of GSK-3β by PI3K-AKT pathway promoted and suppressed, respectively, PME-1 expression in primary cultured neurons, SH-SY5Y cells and in the mouse brain. These findings suggest that GSK-3β phosphorylates β-catenin and suppresses its function on PME-1 expression, resulting in an increase of PP2Ac methylation.
Insights
Glycogen synthase kinase-3β (GSK-3β) regulates Protein phosphatase methylesterase-1 (PME-1) expression by phosphorylating β-catenin. This mechanism controls PP2A methylation and tau phosphatase activity.
Area of Science:
- Neuroscience
- Molecular Biology
- Biochemistry
Background:
- Protein phosphatase 2A (PP2A) is a key tau phosphatase, and its activity is modulated by the methylation of its catalytic subunit (PP2Ac) at Leu309.
- Protein phosphatase methylesterase-1 (PME-1) is responsible for PP2Ac demethylation, thereby reducing PP2A activity.
- Previous research indicated that glycogen synthase kinase-3β (GSK-3β) suppresses PME-1 expression, but the mechanism remained unclear.
Purpose of the Study:
- To elucidate the molecular mechanism by which GSK-3β suppresses PME-1 expression.
- To investigate the role of β-catenin and specific promoter elements in regulating PME-1 expression.
- To determine how the PI3K-AKT pathway influences PME-1 expression via GSK-3β.
Main Methods:
- Promoter analysis of the human PME-1 gene to identify cis-regulatory elements.
- Investigation of the interaction between β-catenin, GSK-3β, and the PME-1 promoter.
- Pharmacological manipulation of GSK-3β activity using the PI3K-AKT pathway in neuronal cells and mouse brain models.
Main Results:
- The human PME-1 promoter contains two lymphoid enhancer binding factor-1/T-cell factor (LEF1/TCF) cis-elements where β-catenin acts as a co-activator to promote PME-1 expression.
- GSK-3β phosphorylates β-catenin, thereby inhibiting its co-activator function and suppressing PME-1 expression.
- Modulation of GSK-3β activity through the PI3K-AKT pathway directly affected PME-1 expression in cultured neurons, SH-SY5Y cells, and the mouse brain.
Conclusions:
- GSK-3β negatively regulates PME-1 expression by phosphorylating β-catenin, which interferes with its ability to promote PME-1 transcription.
- This GSK-3β-β-catenin pathway is a critical determinant of PME-1 levels and, consequently, PP2Ac methylation status.
- The findings reveal a novel regulatory axis controlling tau phosphatase activity with implications for neurodegenerative diseases associated with tau pathology.
Related Concept Videos
Cell Specific Gene Expression
PI3K/mTOR/AKT Signaling Pathway
TGF - β Signaling Pathway
Amplifying Signals via Enzymatic Cascade
cAMP-dependent Protein Kinase Pathways
The JAK-STAT Signaling Pathway


